Article Information
History
- February 1, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Hirofumi Ohashi1,2,
- Feng Wang3,
- Frank Stappenbeck3,
- Kana Tsuchimoto1,
- Chisa Kobayashi1,2,
- Wakana Saso1,4,5,
- Michiyo Kataoka6,
- Kouji Kuramochi2,
- Masamichi Muramatsu1,
- Tadaki Suzuki6,
- Camille Sureau7,
- Makoto Takeda8,
- Takaji Wakita1,
- Farhad Parhami3,* and
- Koichi Watashi1,2,9,10,*
- 1Department of Virology II, National Institute of Infectious Diseases, Tokyo 162-8640, Japan; kwatashi{at}nih.go.jp
- 2Department of Applied Biological Sciences, Tokyo University of Science, Noda 278-8510, Japan
- 3MAX BioPharma, Inc., 2870 Colorado Avenue, Santa Monica, CA 90404, USA; fparhami{at}maxbiopharma.com
- 4The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan
- 5AIDS Research Center, National Institute of Infectious Diseases, Tokyo 162-8640, Japan
- 6Department of Pathology, National Institute of Infectious Diseases, Tokyo 162-8640, Japan
- 7Laboratoire de Virologie Moléculaire, Institut National de la Transfusion Sanguine, Paris 75739, France
- 8Department of Virology III, National Institute of Infectious Diseases, Tokyo 208-0011, Japan
- 9Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto 606-8507, Japan
- 10MIRAI, JST, Saitama 332-0012, Japan
- ↵*Correspondence: e-mail@e-mail.com; Tel.: fparhami{at}maxbiopharma.com; +01-424-581-6025 (F. P), kwatashi{at}nih.go.jp; +81-3-5285-1111 (K. W)